Novavax Stock News

Gaithersburg, Maryland-based Novavax says it achieved 80% efficacy in adolescents aged 12 through 17 in clinical trials across the U.S.

Gaithersburg, Maryland-based Novavax says it achieved 80% efficacy in adolescents aged 12 through 17 in clinical trials across the U.S.

NEW YORK , Feb. 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for HUBS, SQ, AAPL, ZEN, and NVAX. … Full story available on Benzinga.com

GAITHERSBURG, Md., Feb. 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat at the 11th Annual SVB

A new Covid-19 vaccine has been given regulatory approval for use in the UK, after being partly trialled in Northern Ireland.

Novavax will submit applications for clearance of the shot''s use in adolescents to global authorities in first quarter

Highlights Greg Hunt announces Novavax roll out date, will be available from Monday (14 February 2022). A three million dose shipment of the protein-based Covid vaccine has arrived in Australia already. Novavax Inc.s (NYSE:NVAX) protein vaccine will be available to Aussies from Valentines day (14 February 2022). The first shipment of vaccines has already arrived to help boost Australian immunity against Covid and its persisting variant Omicron. The two-dose vaccine is under media spotlight since it got itss approval from the Australian Technical Advisory Group on Immunisation (ATAGI ) and Therapeutic Goods Association (TGA). As announced by Federal Health Minister Greg Hunt, the Novavax covid vaccine will be rolled out across Australia from Monday. Where can you get the Novavax vaccine? The vaccine shots will be administered at state clinics and select general practitioners and pharmacies in the country. As per reports, the vaccine will be supplied to other pharmacies and practitioners from February 21.

The new vaccine will be the first protein-based COVID-19 jab in Australia.

The latest study enrolled 2,247 children from US, aged 12 to 17. It found the vaccine was 80% effective at preventing symptomatic Covid-19 infection.

Australia will begin rolling out the Novavax COVID-19 vaccine at select general practices, community pharmacies, and state clinics across the country for Australians aged 18 and over from Feb. 14, one week earlier than planned. It is the first protein-based vaccine approved for Australians, allowing people who have allergies to certain ingredients used in approved […]

Novavax announced Thursday that its COVID-19 vaccine proved safe and effective in a study of 12- to 17-year-olds.

COVID pandemic, Novavax, covid protein vaccine, vaccine for kids, latest coronavirus pandemic news updates, covid vaccination, Novavax news, Novavax latest news updates

The new vaccine will be the first protein-based COVID-19 jab in Australia.

Novavax says its COVID-19 vaccine safe & effective for kids aged 12

Novavax makes a protein-based vaccine -- a different type than the most widely used shots -- that’s a late arrival to the Covid-19 arsenal.